Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

£60,000 Competition to Recognise Innovative Scientists Launched by BBSRC

Published: Friday, July 12, 2013
Last Updated: Friday, July 12, 2013
Bookmark and Share
Innovator of the Year 2014 competition launched by BBSRC to recognise and reward scientist's whose excellent science and innovations are delivering real world impact.

Innovator of the Year 2014, a prestigious competition from the Biotechnology and Biological Sciences Research Council (BBSRC), is now underway to recognise and reward innovation from BBSRC-funded scientists to deliver real-world impacts.

The competition, now in its sixth year, offers a personal award of £30,000 to the overall winner for taking their research beyond the lab to deliver social and economic benefits.

This year winners in the competition's three categories will each take away greater rewards of £15,000 each, up from £10,000 in previous years, with the overall winner receiving an additional £15,000 to make £30,000 in total prize money to support their research, training or other activities promoting economic or social impact.

Applications are open for entries to the competition's three categories of 'Commercial Innovator', 'Social Innovator' and 'Most Promising Innovator', designed to reflect the breadth of the benefits delivered by BBSRC's investment in UK bioscience.

Entry is open to all BBSRC-funded scientists with the deadline for nominations on 19 September and the deadline for applications 6 November. Nominations can be made by simply filling out a form at www.bbsrc.ac.uk/business/impact-incentive/innovator .

A shortlist of finalists will be completed in January 2014, with the winners to be announced in March 2014.

The finalists will be judged by an expert independent panel. The judges will be looking to recognise those innovators who have worked hardest and have gone furthest to take their science out of the lab to deliver impact.

Last year's winner was Dr Ryan Donnelly of Queen's University Belfast who won the Most Promising Innovator and Overall Innovator titles for his work on hydrogel-based microneedles.
Dr Donnelly said: "Winning BBSRC Innovator of the Year has been the highlight of my career to date. To be recognised in this way is something very special.

"From the point of view of progressing my own microneedle technology, I have already had contact from two world players in the pharma industry as a result of my award from BBSRC, with a view to conducting collaborative projects.

"I would thoroughly recommend academics to apply for BBSRC Innovator of the Year, due to enhanced visibility for their work, increased opportunity to network with peers and the real possibility of initiating collaborations."

Professor Douglas Kell, BBSRC Chief Executive, said: "Innovator of the Year has established itself as a highly respected and much anticipated competition. BBSRC funds world class research across the biosciences and translating that work into benefits for society and the economy is incredibly important.

"This is a great chance to recognise the excellent work that BBSRC-funded scientists do to generate impact and I'm very much looking forward to hearing about what I expect will be a very high calibre of entrants this year."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Drugs Used to Treat Lung Disease Work With the Body Clock
Scientists from The University of Manchester have discovered why medication to treat asthma and pneumonia can become ineffective.
Thursday, August 14, 2014
Prions, vCJD and the Immune System Relay
BBSRC is helping to shed new light on variant Creutzfeldt-Jakob disease.
Friday, December 06, 2013
Researchers Have a Nose for How Probiotics Could Affect Hay Fever
A study has shown that a daily probiotic drink changed how cells lining the nasal passages of hay fever sufferers reacted to a single out-of-season challenge.
Thursday, November 28, 2013
New Technique for Developing Drugs
An international team of researchers have created a new drug for possible use against heart disease, inflammation and other illnesses.
Monday, November 18, 2013
Breaking up the Superbugs’ Party
The fight against antibiotic-resistant superbugs has taken a step forward thanks to a new discovery by scientists.
Friday, August 16, 2013
Scientific News
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
New Strategy for Combating Adenoviruses
Using an animal model they developed, Saint Louis University and Utah State university researchers have identified a strategy that could keep a common group of viruses called adenoviruses from replicating and causing sickness in humans.
Major Advance Toward More Effective, Long-Lasting Flu Vaccine
Collaboration shows vaccine candidate can produce powerful ‘broadly neutralizing antibodies’ in animal models.
Immune System: Help for Killer Cells
A study from the University of Bonn may show the way to more effective vaccines.
Protein Found to Control Inflammatory Response
A new Northwestern Medicine study shows that a protein called POP1 prevents severe inflammation and, potentially, diseases caused by excessive inflammatory responses.
A Leap Forward in Vaccinating Against HIV
A team of scientists has developed an experimental vaccine candidate that successfully stimulates the immune system activity in animal models necessary to stop HIV infection.
MRI Scanners Can Steer Therapeutics to Specific Target Sites
Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
Team Finds Early Inflammatory Response Paralyzes T Cells
Findings could have enormous implications for immunotherapy, autoimmune disorders, transplants and other aspects of immunity.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!